Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells. [electronic resource]
Producer: 20100701Description: 1156-62 p. digitalISSN:- 1349-7006
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- physiology
- Breast Neoplasms -- pathology
- Cell Line, Tumor
- Female
- Humans
- Inhibitor of Apoptosis Proteins
- Microtubule-Associated Proteins -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- physiology
- Proto-Oncogene Proteins c-akt -- physiology
- Receptor, ErbB-2 -- antagonists & inhibitors
- Survivin
- Transcription Factor 4
- Transcription Factors -- physiology
- Trastuzumab
- beta Catenin -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.